One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.
about
Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults studyComment on: "One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients" by Boschetti et al.Growth hormone and the heart in growth hormone deficiency-what have we learned so far?Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks.
P2860
One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
One-year GH replacement therap ...... e (TOD) in adult GHD patients.
@en
One-year GH replacement therapy reduces early cardiac target organ damage
@nl
type
label
One-year GH replacement therap ...... e (TOD) in adult GHD patients.
@en
One-year GH replacement therapy reduces early cardiac target organ damage
@nl
prefLabel
One-year GH replacement therap ...... e (TOD) in adult GHD patients.
@en
One-year GH replacement therapy reduces early cardiac target organ damage
@nl
P2093
P2860
P1433
P1476
One-year GH replacement therap ...... ge (TOD) in adult GHD patients
@en
P2093
Claudia Teti
Claudio Brunelli
Gian Paolo Bezante
Laura Casalino
Mara Boschetti
Sergio Agosti
Valeria Albanese
P2860
P2888
P304
P356
10.1007/S12020-016-0951-4
P577
2016-04-13T00:00:00Z